Walleye Capital’s Calumet Specialty Products CLMT Stock Holding History

Walleye Capital’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15M	Sell	31,915 -304,281	-91%	-$10.2M	﹤0.01%	1996
2026 Q1	$12.1M	Buy	+336,196	New	+$8.7M	0.05%	334
2025 Q4	–	Sell	-43,740	Closed	-$842K	–	4628
2025 Q3	$798K	Sell	43,740 -121,249	-73%	-$1.99M	﹤0.01%	2270
2025 Q2	$2.6M	Buy	164,989 +130,089	+373%	+$1.65M	0.01%	1321
2025 Q1	$443K	Buy	+34,900	New	+$548K	﹤0.01%	2652
2020 Q1	–	Sell	-43,199	Closed	-$157K	–	1028
2019 Q4	$157K	Buy	+43,199	New	+$149K	0.01%	1216

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Walleye Capital's CLMT Position: Q2 2026 in Review

Walleye Capital reduced its Calumet Specialty Products (CLMT) stake by 91% in Q2 2026, selling an estimated $10.2M and leaving 31,915 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Walleye Capital first reported a position in CLMT in Q4 2019 and has held it in 6 quarters since. The position peaked at $12.1M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

Walleye Capital held 31,915 shares of Calumet Specialty Products worth $1.15M as of Q2 2026.
Walleye Capital sold 304,281 Calumet Specialty Products shares in Q2 2026, an estimated $10.2M.
Calumet Specialty Products made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #1996 holding.
Walleye Capital first reported a position in Calumet Specialty Products in Q4 2019 and has held it in 6 quarters since.
Walleye Capital's Calumet Specialty Products position peaked at $12.1M in Q1 2026.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.